For minimal carbohydrate calories. Sold as Dextrose 5% And Potassium Chloride 0.15% In Plastic Container, Dextrose 5% And Potassium Chloride 0.3% In Plastic Container, Dextrose 5% And Potassium Chloride 0.224% In Plastic Container, Dextrose 5% And Potassium Chloride 0.075% In Plastic Container, Potassium Chloride 20meq In Dextrose 5% In Plastic Container and 8 more. Every FDA application for this active ingredient: 4 branded and 1 generic.
As of Nov 15, 2026, FDA lists 5 applications for Dextrose; Potassium Chloride (sold as Dextrose 5% And Potassium Chloride 0.15% In Plastic Container, Dextrose 5% And Potassium Chloride 0.3% In Plastic Container, Dextrose 5% And Potassium Chloride 0.224% In Plastic Container and others), first approved Feb 1, 1979, with 0 new uses approved and 0 published complete response letters.
| Hypernatremia Fluid Therapy in Childhood DiarrhoeaHypernatremia, Acute Watery Diarrhea · International Centre for Diarrhoeal Disease Research, Bangladesh | Not applicable | Enrolling by invitation | Oct 21, 2026 |
| Effects of Pre-Run Nutritional Supplements During a Fixed-Pace 5 km Treadmill RunExercise Physiology, Nutritional Supplementation · St. Louis University | Not applicable | Recruiting | Oct 2, 2026 |
| Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 DiabetesType 2 Diabetes Mellitus, Cardiovascular-Kidney-Metabolic Syndrome · Assiut University | — | Not yet recruiting | Oct 2, 2026 |
| Clinical, Dermoscopic, and Mycological Characteristics of Tinea Capitis in ChildrenFungal Infection by Site, Tinea Capitis · Sohag University | — | Not yet recruiting | Sep 3, 2026 |
| Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver TransplantationLiver Transplant, Carbapenem-resistant Enterobacterales · IRCCS Azienda Ospedaliero-Universitaria di Bologna | Phase 3 | Not yet recruiting | Aug 12, 2026 |
| Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled TrialHypertension (HTN) · Heart Health Research Center | Not applicable | Not yet recruiting | Jul 1, 2026 |
| Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)IBD and Renal Involement, Chronic Kidney Disease · Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji | — | Recruiting | May 18, 2026 |
| Effects of Intensive Glycemic Control in the Postoperative Period of Neurosurgical Patients on the Incidence of Surgical Site InfectionSurgical Site Infection (SSI) · University of Sao Paulo | Not applicable | Not yet recruiting | Apr 23, 2026 |
| Feb 1, 1979 | Dextrose 5% And Potassium Chloride 0.15% In Plastic Container, Dextrose 5% And Potassium Chloride 0.3% In Plastic ContainerNDA 17634 · New formulation or manufacturer | Baxter Hlthcare | 55 | Marketed |
| May 29, 1980 | Potassium Chloride 20meq In Dextrose 5% In Plastic Container, Potassium Chloride 40meq In Dextrose 5% In Plastic ContainerNDA 18371 · New formulation or manufacturer | Otsuka Icu Medcl | 62 | Marketed |
| Nov 9, 1982 | Potassium Chloride 0.075% In Dextrose 5% In Plastic Container, Potassium Chloride 0.15% In Dextrose 5% In Plastic ContainerNDA 18744 · New formulation or manufacturer | B Braun | 7 | Discontinued |
| Sep 29, 1989 | Potassium Chloride 0.037% In Dextrose 5% In Plastic Container, Potassium Chloride 0.075% In Dextrose 5% In Plastic ContainerNDA 19699 · New formulation or manufacturer | B Braun | 13 | Marketed |
| Sep 10, 2020 | Dextrose 5% And Potassium Chloride 0.075%, Dextrose 5% And Potassium Chloride 0.15%ANDA 212346 | Fresenius Kabi USA | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Baxter Hlthcare
Fresenius Kabi USA